ABOUT CONOLIDINE

These benefits, together with a past report demonstrating that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like conduct in mice,2 aid the notion of targeting ACKR3 as a singular approach to modulate the opioid system, which could open up new therapeutic avenues for opioid-related Diseases.According to available science the Conolidine